266 related articles for article (PubMed ID: 27106708)
1. The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors.
Cox JM; Chu HD; Kuethe JT; Gao YD; Scapin G; Eiermann G; He H; Li X; Lyons KA; Metzger J; Petrov A; Wu JK; Xu S; Sinha-Roy R; Weber AE; Biftu T
Bioorg Med Chem Lett; 2016 Jun; 26(11):2622-6. PubMed ID: 27106708
[TBL] [Abstract][Full Text] [Related]
2. Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV.
Namoto K; Sirockin F; Ostermann N; Gessier F; Flohr S; Sedrani R; Gerhartz B; Trappe J; Hassiepen U; Duttaroy A; Ferreira S; Sutton JM; Clark DE; Fenton G; Beswick M; Baeschlin DK
Bioorg Med Chem Lett; 2014 Feb; 24(3):731-6. PubMed ID: 24439847
[TBL] [Abstract][Full Text] [Related]
3. Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes.
Li S; Xu H; Cui S; Wu F; Zhang Y; Su M; Gong Y; Qiu S; Jiao Q; Qin C; Shan J; Zhang M; Wang J; Yin Q; Xu M; Liu X; Wang R; Zhu L; Li J; Xu Y; Jiang H; Zhao Z; Li J; Li H
J Med Chem; 2016 Jul; 59(14):6772-90. PubMed ID: 27396490
[TBL] [Abstract][Full Text] [Related]
4. Anagliptin, a potent dipeptidyl peptidase IV inhibitor: its single-crystal structure and enzyme interactions.
Watanabe YS; Yasuda Y; Kojima Y; Okada S; Motoyama T; Takahashi R; Oka M
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):981-8. PubMed ID: 26147347
[TBL] [Abstract][Full Text] [Related]
5. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
[TBL] [Abstract][Full Text] [Related]
6. Substituted piperidinyl glycinyl 2-cyano-4,5-methano pyrrolidines as potent and stable dipeptidyl peptidase IV inhibitors.
Zhao G; Kwon C; Wang A; Robertson JG; Marcinkeviciene J; Parker RA; Kirby MS; Hamann LG
Bioorg Med Chem Lett; 2013 Mar; 23(6):1622-5. PubMed ID: 23416006
[TBL] [Abstract][Full Text] [Related]
7. Structure-Activity Relationship Analysis of Cocrystallized Gliptin-like Pyrrolidine, Trifluorophenyl, and Pyrimidine-2,4-Dione Dipeptidyl Peptidase-4 Inhibitors.
Tomovic K; Ilic BS; Smelcerovic A
J Med Chem; 2021 Jul; 64(14):9639-9648. PubMed ID: 34190540
[TBL] [Abstract][Full Text] [Related]
8. Rational design and synthesis of potent and long-lasting glutamic acid-based dipeptidyl peptidase IV inhibitors.
Tsai TY; Hsu T; Chen CT; Cheng JH; Chiou MC; Huang CH; Tseng YJ; Yeh TK; Huang CY; Yeh KC; Huang YW; Wu SH; Wang MH; Chen X; Chao YS; Jiaang WT
Bioorg Med Chem Lett; 2009 Apr; 19(7):1908-12. PubMed ID: 19269819
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity-relationship of amide and sulfonamide analogs of omarigliptin.
Chen P; Feng D; Qian X; Apgar J; Wilkening R; Kuethe JT; Gao YD; Scapin G; Cox J; Doss G; Eiermann G; He H; Li X; Lyons KA; Metzger J; Petrov A; Wu JK; Xu S; Weber AE; Yan Y; Roy RS; Biftu T
Bioorg Med Chem Lett; 2015 Dec; 25(24):5767-71. PubMed ID: 26546218
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Wu Y; Wu H; Tang L; Wu P; Liu T; Hu Y
Chem Biol Drug Des; 2013 Aug; 82(2):140-6. PubMed ID: 23530834
[TBL] [Abstract][Full Text] [Related]
11. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes.
Deng J; Peng L; Zhang G; Lan X; Li C; Chen F; Zhou Y; Lin Z; Chen L; Dai R; Xu H; Yang L; Zhang X; Hu W
Eur J Med Chem; 2011 Jan; 46(1):71-6. PubMed ID: 21106276
[TBL] [Abstract][Full Text] [Related]
12. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors.
Tanwar O; Tanwar L; Shaquiquzzaman M; Alam MM; Akhter M
Bioorg Med Chem Lett; 2014 Aug; 24(15):3447-51. PubMed ID: 24948564
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of tetrahydropyridopyrimidine derivatives as dual GPR119 and DPP-4 modulators.
Fang Y; Zhang S; Wu W; Liu Y; Yang J; Li Y; Li M; Dong H; Jin Y; Liu R; Yang Z
Bioorg Chem; 2020 Jan; 94():103390. PubMed ID: 31662212
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and potent inhibitory activities of carboxybenzyl-substituted 8-(3-(R)-aminopiperidin-1-yl)-7-(2-chloro/cyanobenzyl)-3-methyl-3,7-dihydro-purine-2,6-diones as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Mo DW; Dong S; Sun H; Chen JS; Pang JX; Xi BM; Chen WH
Bioorg Med Chem Lett; 2015 May; 25(9):1872-5. PubMed ID: 25838146
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV.
Zhang Z; Wallace MB; Feng J; Stafford JA; Skene RJ; Shi L; Lee B; Aertgeerts K; Jennings A; Xu R; Kassel DB; Kaldor SW; Navre M; Webb DR; Gwaltney SL
J Med Chem; 2011 Jan; 54(2):510-24. PubMed ID: 21186796
[TBL] [Abstract][Full Text] [Related]
17. Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group.
Yoshida T; Akahoshi F; Sakashita H; Sonda S; Takeuchi M; Tanaka Y; Nabeno M; Kishida H; Miyaguchi I; Hayashi Y
Bioorg Med Chem; 2012 Aug; 20(16):5033-41. PubMed ID: 22824762
[TBL] [Abstract][Full Text] [Related]
18. ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitus.
Jain MR; Joharapurkar AA; Kshirsagar SG; Patel VJ; Bahekar RH; Patel HV; Jadav PA; Patel PR; Desai RC
Br J Pharmacol; 2017 Jul; 174(14):2346-2357. PubMed ID: 28452143
[TBL] [Abstract][Full Text] [Related]
19. Optimization of the benzamide fragment targeting the S
Deng X; Wang N; Meng L; Zhou S; Huang J; Xing J; He L; Jiang W; Li Q
Bioorg Chem; 2020 Jan; 94():103366. PubMed ID: 31640932
[TBL] [Abstract][Full Text] [Related]
20. Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes.
Sutton JM; Clark DE; Dunsdon SJ; Fenton G; Fillmore A; Harris NV; Higgs C; Hurley CA; Krintel SL; MacKenzie RE; Duttaroy A; Gangl E; Maniara W; Sedrani R; Namoto K; Ostermann N; Gerhartz B; Sirockin F; Trappe J; Hassiepen U; Baeschlin DK
Bioorg Med Chem Lett; 2012 Feb; 22(3):1464-8. PubMed ID: 22177783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
